At the BioTrinity Conference, experts champion government funding programmes to bridge gaps in UK venture capital financing.
|
 |
Panellists at the OBN BioTrinity 2025 conference in London discussed how US uncertainty is impacting the biopharma environment.
|
 |
The study concluded that treatment with SGLT-2I in conjunction with GLP-1RA may help to reduce the incidence of AF/flutter and stroke in T2D patients.
|
 |
Subdermal implants, changed once or twice per year, could deliver GLP-1R agonist with no need for a weekly injection.
|
 |
Bio-Thera Solutions, the developer of the biosimilar, will continue to hold manufacturing rights in the US market.
|
 |
The approval is supported by a prespecified interim analysis from the ongoing, randomised Phase III ALIGN trial.
|
 |
The agreement stipulates that projects will be co-selected, drawing on shared interests and areas of expertise.
|
 |